Understanding the needs of patients who use both methamphetamines and opioids in hospitals
Characteristics and outcomes for hospitalized patients with methamphetamine and opioid co-use: Identifying opportunities for hospital-based addiction services tailored to co-use
This study is looking at how people who use both methamphetamines and opioids are treated in the hospital, so we can find better ways to help them get the care they need.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-11042176 on NIH RePORTER |
What this research studies
This research investigates the characteristics and outcomes of patients who are hospitalized due to the co-use of methamphetamines and opioids. It aims to identify how existing hospital addiction services can be improved to better serve these patients, who often have different needs compared to those using opioids alone. By analyzing patient demographics and hospitalization details, the study seeks to develop tailored treatment approaches that enhance care and support for individuals facing these dual addictions. The findings could lead to more effective hospital-based addiction services that address the unique challenges of co-use.
Who could benefit from this research
Good fit: Ideal candidates for this research are hospitalized individuals who are using both methamphetamines and opioids.
Not a fit: Patients who are not using either methamphetamines or opioids may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved addiction treatment services in hospitals, ultimately reducing overdose deaths and enhancing recovery outcomes for patients with co-use disorders.
How similar studies have performed: While there has been significant research on opioid use alone, this approach to studying co-use of methamphetamines and opioids is relatively novel and has not been extensively tested.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Shearer, Riley — University of Minnesota
- Study coordinator: Shearer, Riley
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.